{"id":"W2084941037","doi":"10.1007/s10549-010-1022-9","title":"Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":89,"is_retracted":false,"has_abstract":false,"ca_institutions":"Regional Municipality of Durham; Jewish General Hospital; University of Toronto; Sunnybrook Health Science Centre","funders":"AstraZeneca","keywords":"Fulvestrant; Tolerability; Medicine; Discontinuation; Dosing; Breast cancer; Internal medicine; Clinical endpoint; Hazard ratio; Cancer; Pharmacokinetics; Aromatase inhibitor; Oncology; Gastroenterology; Urology; Confidence interval; Adverse effect; Randomized controlled trial; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002675027,0.0002007767,0.0003233734,0.0001239103,0.0001200645,0.00001356809,0.0001165793,0.00009382293,0.000009430715],"category_scores_gemma":[0.000004833688,0.0001393198,0.00002497949,0.0002263997,0.0002573162,0.000009210982,0.0000962127,0.0002242242,2.560911e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009849351,"about_ca_system_score_gemma":0.0003482088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004882962,"about_ca_topic_score_gemma":0.005995005,"domain_scores_codex":[0.9984777,0.00007215622,0.0002612604,0.0004373915,0.0002761717,0.0004753218],"domain_scores_gemma":[0.9992073,0.00002196477,0.000103938,0.0003267474,0.0001557252,0.000184378],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.03516737,0.006139343,0.0552828,0.0000448695,0.0006334563,0.0000719005,0.001193618,0.0001107798,0.8261217,0.00001955513,0.00001000401,0.07520457],"study_design_scores_gemma":[0.0874632,0.07280749,0.5492436,0.0005273546,0.0001524293,0.0004265424,0.002340816,0.0001694762,0.2860056,0.00005437677,0.0001765351,0.0006325449],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975528,0.0009437513,0.000001090201,0.0001913331,0.00003111083,0.0008159113,0.0003269888,0.000005468432,0.0001315913],"genre_scores_gemma":[0.9990186,0.0004867516,0.00004921688,0.000003021607,0.00005270373,0.0002927879,0.00002426639,0.00002157609,0.00005104227],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5401161,"threshold_uncertainty_score":0.738161,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02062371587390918,"score_gpt":0.3414630079312039,"score_spread":0.3208392920572947,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}